1,3 DMAA

1,3-DMAA (Methylhexanamine) Research Standard

1,3-DMAA (1,3-dimethylamylamine; methylhexanamine) is a synthetic aliphatic amine utilized in neuropharmacological and adrenergic research. Structurally categorized as a sympathomimetic amine, 1,3-DMAA acts primarily as an indirect adrenergic agonist. In laboratory research, it serves as a specialized ligand for investigating the structure-activity relationship (SAR) of phenethylamine-like scaffolds and the modulation of norepinephrine release within adrenergic signaling pathways.

Technical Specifications

Mechanism of Action & Research Context

The research interest in 1,3-DMAA is defined by its role as an indirect sympathomimetic agent.

• Adrenergic Modulation: 1,3-DMAA acts by stimulating the release of norepinephrine from presynaptic nerve terminals. This mechanism mimics the activity of endogenous catecholamines, making it a useful probe for studying the adrenergic system.

• Sympathomimetic Pharmacology: As a structural analog within the broader class of sympathomimetic amines, it is used to evaluate how small structural changes (such as the aliphatic chain arrangement in 1,3-DMAA) alter potency and efficacy compared to classical phenethylamines.

• Receptor Interaction: Investigations focus on its ability to traverse synaptic membranes and influence catecholamine transporter systems, effectively increasing the concentration of norepinephrine available for post-synaptic adrenergic receptor binding.

Research Applications

1,3-DMAA is a specialized reagent essential for comparative pharmacology and adrenergic signaling research.

Primary fields of in vitro and laboratory investigation include:

• Adrenergic Signaling Pathways: Evaluating the release kinetics and signaling outcomes of norepinephrine modulation in isolated neuronal preparations.

• Structure-Activity Relationship (SAR) Panels: Utilizing 1,3-DMAA as a reference aliphatic amine to determine the influence of specific molecular structures on sympathomimetic activity.

• Receptor Pharmacology: Benchmarking the compound’s activity against other adrenergic ligands to map receptor selectivity and potency within the adrenergic receptor system.

• Molecular Docking & Transporter Analysis: Studying the interaction of the methylhexanamine scaffold with catecholamine transporters to elucidate mechanism-of-action nuances.

Storage & Handling Guidelines

To maintain the chemical stability and experimental reliability of the compound:

• Storage Environment: Store in a cool, dry place. Protect strictly from light, moisture, and high temperatures, which may affect the stability of the aliphatic amine structure.

• Lot Verification: Always consult the specific Lot Certificate of Analysis (COA) provided, as the physical state (liquid vs. crystalline salt form) may influence handling procedures.

• Handling: Treat as a potent research chemical. Utilize standard laboratory safety practices, including appropriate PPE, and ensure adequate ventilation during preparation of solutions.

• Container Integrity: Keep the container tightly sealed when not in use to prevent volatility and moisture ingress.

Research Use Disclaimer

Research Use Only Disclaimer: This product is developed and distributed strictly as a Research Use Only (RUO) laboratory reference chemical intended exclusively for non-clinical analytical and scientific investigation. It is not an FDA-approved drug, medical treatment, dietary supplement, or food ingredient, and is strictly prohibited for human or animal consumption. Kimera Chems supplies this high-purity research material solely to qualified institutions and professional investigators for authorized laboratory research.